Numis Securities Ltd reaffirmed their add rating on shares of Spire Healthcare Group PLC (LON:SPI) in a research note issued to investors on Thursday. The firm currently has a GBX 350 ($4.52) target price on the stock.
Other equities analysts also recently issued reports about the stock. Liberum Capital reissued a buy rating and set a GBX 400 ($5.17) price target on shares of Spire Healthcare Group PLC in a report on Friday, May 26th. Berenberg Bank lifted their price target on shares of Spire Healthcare Group PLC from GBX 360 ($4.65) to GBX 390 ($5.04) and gave the company a buy rating in a report on Wednesday, June 21st. Jefferies Group LLC lifted their price target on shares of Spire Healthcare Group PLC from GBX 305 ($3.94) to GBX 350 ($4.52) and gave the company a hold rating in a report on Thursday, June 1st. Finally, Credit Suisse Group reissued an underperform rating on shares of Spire Healthcare Group PLC in a report on Friday, July 21st. One research analyst has rated the stock with a sell rating, five have issued a hold rating and one has given a buy rating to the company. Spire Healthcare Group PLC currently has a consensus rating of Hold and an average price target of GBX 347 ($4.48).
Spire Healthcare Group PLC (SPI) opened at 260.20 on Thursday. The firm has a 50-day moving average of GBX 327.79 and a 200 day moving average of GBX 332.90. Spire Healthcare Group PLC has a 52-week low of GBX 228.48 and a 52-week high of GBX 411.00. The company’s market cap is GBX 1.04 billion.
Spire Healthcare Group PLC (LON:SPI) last announced its quarterly earnings results on Thursday, September 14th. The company reported GBX 8.70 ($0.11) earnings per share (EPS) for the quarter, beating the consensus estimate of GBX 8.60 ($0.11) by GBX 0.10 ($0.00). Spire Healthcare Group PLC had a net margin of 3.92% and a return on equity of 3.47%. The firm had revenue of £481 million during the quarter. Equities research analysts expect that Spire Healthcare Group PLC will post $18.48 earnings per share for the current fiscal year.
WARNING: This news story was published by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are reading this news story on another site, it was stolen and republished in violation of US and international trademark and copyright law. The legal version of this news story can be viewed at https://www.chaffeybreeze.com/2017/09/17/numis-securities-ltd-reaffirms-add-rating-for-spire-healthcare-group-plc-spi.html.
About Spire Healthcare Group PLC
Spire Healthcare Group plc is a United Kingdom-based independent hospital group. The Company provides in-patient, daycase and out-patient care from approximately 40 hospitals, 10 clinics and over two specialist care centers across the United Kingdom. The Company also owns and operates a sports medicine, physiotherapy and rehabilitation brand, Perform, and a screening service, Lifescan, as well as national pathology services.
Receive News & Ratings for Spire Healthcare Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.